Article
Effect of 5-Azacitine Treatment on Redox Status and Inflammatory Condition in MDS Patients
2021-12-08
Abstract excerpt
This study focused on the impact of the treatment with the hypomethylating agent 5-Azacitidine on the redox status and inflammation in 24 MDS patients. Clinical and genetic features of MDS patients were recorded and peripheral blood samples were used to determine the activity of the endogenous antioxidant defense system (superoxide dismutase, SOD, catalase, CAT, glutathion peroxidase, GPx, and reductase, GRd, acti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8f8da4c0-d0b1-5246-8c34-f33a468addb9
- DOI
- 10.20944/preprints202112.0137.v1
